sepsis - Nursing Case Study
Pathophysiology
• Primary mechanism: Sepsis begins with a systemic inflammatory response to an infection, leading to widespread release of pro-inflammatory cytokines. This hyper-inflammatory state disrupts normal immune regulation and causes widespread tissue damage.
• Secondary mechanism: The excessive inflammation results in endothelial dysfunction and increased vascular permeability. Consequently, this leads to leakage of fluid from blood vessels, causing hypotension and impaired tissue perfusion, which can progress to septic shock.
• Key complication: The combination of hypotension and tissue hypoxia may result in multiple organ dysfunction syndrome (MODS), where organs such as the kidneys, liver, and lungs fail to function properly, increasing the risk of patient morbidity and mortality.
Patient Profile
Demographics:
55-year-old female, nurse
History:
• Key past medical history: Hypertension, Type 2 Diabetes
• Current medications: Lisinopril, Metformin, Insulin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Shortness of breath and confusion
• Key symptoms: Fever, chills, increased heart rate, decreased urine output
• Vital signs: Temperature 101.8°F, Heart rate 115 bpm, Respiratory rate 24 breaths/min, Blood pressure 90/60 mmHg, Oxygen saturation 91% on room air
Section 1
As the healthcare team continued to monitor the patient, new diagnostic results revealed a significant elevation in lactate levels, indicating worsening lactic acidosis. Her lactate level was measured at 4.2 mmol/L, suggesting impaired tissue perfusion and the potential progression towards septic shock. Blood cultures were obtained, and the results confirmed the presence of gram-negative bacteria, indicating a likely source of infection. This prompted the initiation of broad-spectrum IV antibiotics, excluding any penicillin-based drugs due to her known allergy. Additionally, the patient's white blood cell count was markedly elevated at 18,000/mm³, further confirming the systemic inflammatory response.
Despite these interventions, the patient's condition showed signs of deterioration. Her respiratory status declined, with oxygen saturation dropping to 88% on room air, necessitating supplemental oxygen via nasal cannula at 4 liters per minute. The ongoing hypotension, unresponsive to initial fluid resuscitation, required the introduction of vasopressor support to maintain her blood pressure and improve tissue perfusion. Her urine output remained low at 15 mL/hr, raising concerns about acute kidney injury as part of the developing MODS.
These developments required the healthcare team to reevaluate the patient's treatment plan and consider additional diagnostic testing to assess potential organ dysfunction. The focus moved towards optimizing her hemodynamic status, supporting respiratory function, and closely monitoring renal output to prevent further complications. The team prepared for possible intensive care unit transfer, recognizing the need for more advanced monitoring and interventions to prevent further progression of MODS and improve patient outcomes.
Section 2
As the healthcare team continued to closely monitor the patient, her condition further evolved, prompting additional diagnostic evaluations. New laboratory results revealed a significant decline in platelet count, dropping to 90,000/mm³ from earlier levels, indicating the development of thrombocytopenia. This finding, alongside the existing elevation in lactate and white blood cell count, raised the suspicion of disseminated intravascular coagulation (DIC) as a complication of sepsis. The team ordered a coagulation profile, which showed prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT), further supporting this concern.
The patient's respiratory status also continued to decline despite supplemental oxygen therapy. Arterial blood gas analysis demonstrated a worsening metabolic acidosis with a pH of 7.30, PaCO2 of 32 mmHg, and HCO3 of 16 mEq/L, reflecting a compensatory respiratory response to metabolic derangements. With her oxygen saturation persistently low, the decision was made to escalate respiratory support, transitioning her from nasal cannula to a high-flow nasal cannula at 50 liters per minute, with a FiO2 of 60%.
In light of these developments, the medical team intensified their focus on stabilizing the patient's hemodynamic and respiratory status. Vasopressor therapy was adjusted, with norepinephrine titrated to maintain a mean arterial pressure (MAP) above 65 mmHg. Concurrently, nephrology and hematology consultations were sought to further assess the risk of acute kidney injury and manage potential coagulation disorders. The multidisciplinary approach aimed to prevent further complications of multiple organ dysfunction syndrome (MODS) and optimize the patient's chances of recovery as she approached the threshold for intensive care unit transfer.
Section 3
As the patient was transitioned to high-flow nasal cannula, the healthcare team closely monitored her response to the increased respiratory support. Over the next few hours, her oxygen saturation improved modestly, reaching 92%, but her clinical picture continued to deteriorate. Vital signs revealed a persistently elevated heart rate of 115 beats per minute and a blood pressure of 88/54 mmHg, indicating ongoing hemodynamic instability despite norepinephrine support. The team noted new-onset confusion and agitation, suggesting potential encephalopathy secondary to sepsis-related hypoperfusion and hypoxia.
Further diagnostic evaluations were conducted to assess the patient's renal function and inflammatory status. New laboratory results showed a rising creatinine level of 2.1 mg/dL from a baseline of 1.0 mg/dL, indicating acute kidney injury (AKI) likely due to sepsis-associated hypotension and possible prerenal azotemia. Additionally, C-reactive protein (CRP) and procalcitonin levels remained markedly elevated, underscoring the ongoing systemic inflammatory response. Despite aggressive fluid resuscitation and vasopressor adjustments, the patient's urine output had decreased to less than 0.5 mL/kg/hr, raising further concerns of renal compromise.
In light of these developments, the medical team prioritized the need for renal protective strategies while continuing to address the patient's coagulation abnormalities. Hematology recommended administering fresh frozen plasma and cryoprecipitate to manage the disseminated intravascular coagulation, while nephrology initiated discussions regarding the potential need for renal replacement therapy should the patient's renal function continue to decline. With the patient's condition on the brink of multiple organ dysfunction syndrome, the decision was made to transfer her to the intensive care unit for closer monitoring and more intensive management, setting the stage for the next phase of her critical care journey.
Section 4
In the intensive care unit, the medical team conducted a comprehensive initial assessment of the patient, focusing on her neurological, cardiovascular, and renal status. Her Glasgow Coma Scale score was 12, with marked disorientation and agitation, reinforcing the suspicion of sepsis-associated encephalopathy. Neurological examination revealed sluggish pupillary response and asterixis, indicative of metabolic encephalopathy. Cardiovascular assessment showed persistent tachycardia with a heart rate of 118 beats per minute and hypotension with blood pressure readings fluctuating between 85/50 mmHg and 90/55 mmHg, despite the escalation of norepinephrine infusion. The patient's skin was cool and mottled, further pointing to compromised peripheral perfusion.
New diagnostic results highlighted the progression of her renal impairment, with serum creatinine rising to 2.6 mg/dL and blood urea nitrogen (BUN) climbing to 45 mg/dL. The urine output remained critically low at 0.3 mL/kg/hr. Arterial blood gas analysis revealed a mixed metabolic and respiratory acidosis with a pH of 7.28, PaCO2 of 50 mmHg, and HCO3- of 18 mEq/L, reflecting both hypoventilation and renal dysfunction. The ongoing inflammatory response was corroborated by persistently elevated CRP and procalcitonin levels. These findings indicated a worsening of the patient's multi-organ dysfunction, with her renal failure now at the forefront.
In response to these developments, the healthcare team initiated renal replacement therapy in the form of continuous venovenous hemofiltration (CVVH) to address the acute kidney injury and mitigate fluid overload. Neurology was consulted to evaluate the need for further interventions to manage the encephalopathy, while the critical care team adjusted the vasopressor regimen to optimize hemodynamic support. As the patient's condition continued to evolve, the focus remained on stabilizing her organ systems and preventing further deterioration, setting the stage for potential recovery or the emergence of new complications.
Section 5
As the critical care team closely monitored the patient following the initiation of continuous venovenous hemofiltration (CVVH), a change in her status became evident. Over the next 12 hours, the patient's neurological status showed subtle improvement; her Glasgow Coma Scale score increased to 13, with a slight reduction in agitation. This suggested a positive response to the clearance of metabolic waste products by CVVH, hinting at the reversible nature of her encephalopathy. However, despite these neurological improvements, her cardiovascular status remained a concern. The patient's heart rate persisted at 115 beats per minute, and blood pressure readings continued to hover around 88/52 mmHg, even with the careful titration of norepinephrine and the addition of vasopressin to help stabilize her hemodynamics.
In terms of new diagnostic results, repeat laboratory tests revealed a slight improvement in her acid-base balance, with a pH climbing to 7.32 and bicarbonate levels improving to 20 mEq/L. However, her lactate levels remained elevated at 3.5 mmol/L, indicating ongoing tissue hypoperfusion despite aggressive hemodynamic support. Additionally, an echocardiogram was performed to assess cardiac function more thoroughly, revealing a moderately reduced ejection fraction of 40%, consistent with septic cardiomyopathy. This finding prompted the team to initiate a low-dose inotropic agent to enhance cardiac output and further support perfusion.
The patient's renal function showed early signs of stabilization, with serum creatinine levels plateauing at 2.5 mg/dL after the initiation of CVVH. However, her urine output remained low, suggesting possible ongoing renal dysfunction. Despite these challenges, the team remained vigilant in their efforts to balance fluid status, electrolyte levels, and hemodynamic parameters. As the patient's condition continued to stabilize, albeit slowly, the focus shifted towards preventing new complications such as secondary infections or deep vein thrombosis, given her prolonged immobility and critical illness. These considerations would guide the next phase of her treatment plan, emphasizing the importance of vigilant monitoring and adaptive clinical reasoning.